Secrin M 1 mg+500 mg (Tablet (Extended Release))
Unit Price: ৳ 9.00 (7 x 4: ৳ 252.00)
Strip Price: ৳ 36.00
Medicine Details
Category | Details |
---|---|
Generic | Glimepiride metformin |
Company | Square pharmaceuticals plc |
Also available as |
Indications and Usage
- Adjunct to diet and exercise in type 2 diabetes mellitus patients
- Inadequate glycemic control with monotherapy of glimepiride or metformin
- Replacement of combination therapy of glimepiride and metformin
Pharmacology
- Decreases blood glucose concentration
- Stimulates the release of insulin from pancreatic beta cells
- Improves sensitivity of beta cells to glucose stimulus
- Reduces basal hepatic glucose production
- Increases peripheral tissue sensitivity to insulin
- Improves glucose uptake
Dosage
- Governed by desired blood glucose level
- Lowest effective dosage for desired metabolic control
- Regular measurement of blood and urine glucose levels
- Avoidance of larger doses to correct mistakes
- Potential reduction of glimepiride requirements as treatment proceeds
Administration
- Must be swallowed whole
- Not to be crushed or chewed
Interaction
- Metabolized by cytochrome P450 2C9 (CYP2C9)
- Potentiation of blood-glucose-lowering effect with insulin and other oral antidiabetics
- Weakening of blood-glucose-lowering effect with corticosteroids and diazoxide
- Alcohol intake may influence blood-glucose-lowering action
- Bile acid sequestrant (e.g., colesevelam) reduces glimepiride absorption
Contraindications
- Hypersensitivity to glimepiride, metformin, or sulfonylureas
- Pregnancy and breastfeeding for glimepiride
- Acute metabolic acidosis or severe renal failure for metformin
Side Effects
- Hypoglycemia
- Temporary visual impairment
- Gastrointestinal symptoms like nausea, vomiting, and diarrhea
- Potential liver enzyme elevation and hepatitis
- Hematological changes like thrombocytopenia and anemia
Pregnancy and Lactation
- Avoidance during pregnancy for both glimepiride and metformin
- Avoidance during lactation for glimepiride
- Consideration of nursing discontinuation or metformin cessation in lactating mothers
Precautions and Warnings
- Increased risk of hypoglycemia in initial weeks of treatment
- Increased risk of hypoglycemia during illness or lifestyle changes
- Caution in patients with G6PD-deficiency for glimepiride
- Regular monitoring of thyroid-stimulating hormone (TSH) levels for metformin
Use in Special Populations
- Insufficient data for pediatric use
- Assessment of GFR before initiation and at least annual monitoring for renal impairment
Overdose Effects
- Severe life-threatening hypoglycemia for glimepiride overdose
- Potential lactic acidosis for high metformin doses
- Pancreatitis in the context of a metformin overdose
Therapeutic Class
- Combination oral hypoglycemic preparations
Storage Conditions
- Cool and dry place, protected from light
Related Brands
- Losucon M 1 mg+500 mg (Tablet (Sustained Release)) - incepta-pharmaceuticals-ltd
- Gemer 1 mg+500 mg (Tablet (Extended Release)) - sun-pharmaceutical-bangladesh-ltd
- Amaryl M 1 mg+500 mg (Tablet (Prolonged Release)) - synovia-pharma-plc
- Amaryl M 2 mg+500 mg (Tablet (Prolonged Release)) - synovia-pharma-plc
- Dieta M 1 mg+500 mg (Tablet (Extended Release)) - pacific-pharmaceuticals-ltd